Table 2.
Gene locus | SNP | Comments | Population | Clinical observation | Reference |
---|---|---|---|---|---|
MIR27A | rs895919 *C | Asians | No risk association | 141 | |
Caucasians | Protective | ||||
Jewish BRCA2 carriers | Increased risk | 142 | |||
rs895819 A/G | pre-miRNA | Caucasian | Decreased risk | 143 | |
pre-miRNA | Asians | No risk association | 144 | ||
Caucasians | Decreased risk | ||||
pre-miRNA | Chinese (young) | Decreased risk | 35 | ||
pre-miRNA | Chinese | Decreased risk | 34 | ||
Asians | No risk association | 31 | |||
Caucasians | No risk association | ||||
MIR34B cluster | rs4938723 T/C | African Americans | Increased survival | 145 | |
MIR100 | rs1834306 G/A | African Americans | No risk association | 33 | |
European Americans | Decreased overall risk | ||||
MIR101-2 | rs1053872 C/G | Primary transcript | Chinese | Increased risk | 38 |
rs462480 A/C | Primary transcript | Chinese | Increased risk | 38 | |
MIR106B | rs1527423 A/G | African Americans | No risk association | 33 | |
European Americans | Increased overall risk | ||||
MIR122A | rs17669 A/G | African Americans | Decreased risk of ER+ BC | 33 | |
European Americans | No risk association | ||||
MIR146A | rs2910164 G/C | Italian | Earlier age of onset | 146 | |
Caucasians | No risk association | 147 | |||
Chinese | No risk association | 83 | |||
Asians | No risk association | 38 | |||
Caucasians | No risk association | ||||
Asians | Decreased risk (C allele) | 144 | |||
Asians | No risk association | 31 | |||
Caucasians | No risk association | ||||
Chinese | No risk association | 36 | |||
MIR149 | rs2292832 T/G | Asians | No risk association | 38 | |
Caucasians | No risk association | ||||
Chinese | No risk association | 36 | |||
Asians | No risk association | 31 | |||
Caucasians | No risk association | ||||
MIR185 | rs2008591 C/T | African Americans | Reduced risk | 145 | |
rs887205 A/G | African Americans | Reduced risk | 145 | ||
MIR196A-2 | rs11614913 T/C | Korean | Survival of HER2+ cases | 148 | |
Italian and German | No risk association | 37 | |||
Asians | Decreased risk | 141 | |||
Caucasians | No risk association | ||||
Brazilian | Decreased risk | 149 | |||
Caucasian | Decreased risk | 147 | |||
Chinese and Korean | Decreased risk | 32 | |||
Chinese | Increased risk | 36 | |||
Chinese | Increased risk | 83 | |||
African Americans | No risk association | 33 | |||
European Americans | No risk association | ||||
Asians | No risk association | 31 | |||
Caucasians | No risk association | ||||
MIR204 | rs7861254 G | African Americans | Decreased risk of ER− BC | 33 | |
European Americans | No risk association | ||||
MIR206 | rs6920648 A/G | African Americans | Increased survival | 145 | |
MIR219 | rs107822 G/A | African Americans | Increased risk of ER− BC | 33 | |
European Americans | No risk association | ||||
MIR331 | rs11107973 A/G | African Americans | No risk association | 33 | |
European Americans | Increased overall risk | ||||
MIR373 | rs12983273 T/C | Asians | No risk association | 38 | |
Caucasians | No risk association | ||||
MIR423 | rs6505162 A/C | pre-miRNA | Caucasian | Reduced risk | 150 |
Jewish BRCA2 carriers | Later age of onset | 142 | |||
Asians | No risk association | 38 | |||
Caucasians | No risk association | ||||
MIR455 | rs2060133 C/G | African Americans | No risk association | 33 | |
European Americans | Decreased risk of ER+ BC | ||||
MIR487 | rs1951032 G/A | African Americans | No risk association | 33 | |
European Americans | Increased overall risk | ||||
MIR495 | rs2281611 C/A | African Americans | No risk association | 33 | |
European Americans | Increased risk of ER− BC | ||||
MIR499 | rs3746444 A/G | Chinese | Increased risk | 36 | |
Asians | Increased risk | 151 | |||
Caucasians | No risk association | ||||
Asians | Increased risk | 152 | |||
Caucasians | No risk association | ||||
Chinese | Increased risk | 32 | |||
Caucasians | No risk association | 147 | |||
rs3746444 T/C | Asians | Increased risk | 153 | ||
Caucasians | No risk association | ||||
Asians | Increased risk | 31 | |||
Caucasians | No risk association | ||||
Asians | Decreased risk | 141 | |||
Caucasians | No risk association | ||||
MIR513A-2 | rs2018562 A/G | African Americans | Increased overall risk | 33 | |
European Americans | No risk association | ||||
MIR544 | rs10144193 A/T | African Americans | No risk association | 33 | |
European Americans | Increased overall risk | ||||
MIR548A-2 | rs878175 A/G | African Americans | No risk association | 33 | |
European Americans | Decreased risk of ER+ BC | ||||
MIR595 | rs4909238 A/G | African Americans | Increased risk of ER− BC | 33 | |
European Americans | No risk association | ||||
MIR605 | rs2043556 *A | Asians | Decreased risk | 141 | |
Caucasians | No risk association | ||||
MIR606 | rs12266981 G/A | African Americans | Increased risk of ER+ | 33 | |
European Americans | No risk association | ||||
MIR608 | rs4919510 C/G | African Americans | No risk association | 33 | |
European Americans | Decreased risk of ER− BC | ||||
MIR628 | rs8041885 A/G | African Americans | Decreased risk of ER+ BC | 33 | |
European Americans | No risk association | ||||
rs8041044 C/A | African Americans | Decreased risk of ER+ | 33 | ||
European Americans | No risk association | ||||
MIR659 | rs5750504 T/A | African Americans | No risk association | 33 | |
European Americans | Increased overall risk | ||||
MIR758 | rs12586258 G/A | African Americans | Decreased overall risk | 33 | |
European Americans | No risk association | ||||
rs7141987 A/G | African Americans | No risk association | 33 | ||
European Americans | Increased risk of ER− BC | ||||
ATF1 3′ UTR | rs11169571 C/T | miR-320 MRE | Jewish BRCA2 carriers | Increased risk | 142 |
BMPR1B 3′ UTR | rs1434536 C/T | miR-125b MRE | Caucasian | Increased risk | 43 |
BRCA1 3′ UTR | rs799917 C/T | miR-638 MRE | Italian | Increased risk | 154 |
HPGD 3′ UTR | rs8752 G/A | miR-485-5p MRE | Chinese | Increased risk in ER+ | 155 |
IGF-1R 3′ UTR | rs28674628 A/G | miR-515-5p MRE | Jewish BRCA1 carriers | Earlier age of onset | 156 |
IL23R 3′ UTR | rs10889677 A/C | let-7 MRE | Chinese | Increased risk (A allele) | 157 |
Earlier age of onset (C allele) | |||||
Decreased risk | 158 | ||||
IQGAP1 3′ UTR | rs1042538 A/T | miR-124 MRE | Chinese | Decreased risk | 159 |
ITGB4 3′ UTR | rs743554 A/G | miR-34a MREpredicted | Swedish | Increased risk | 160 |
Reduced survival | |||||
KRAS 3′ UTR | rs61764370 T/G | let-7 MRE | Caucasian | Increased frequency in BRCA1 | 40 |
carriers/no risk association | |||||
Increased risk of TNBC | 39 | ||||
RAD52 3′ UTR | rs7963551 A/C | let-7 MRE | Chinese | Decreased risk | 42 |
RYR3 3′ UTR | rs1044129 A/G | miR-367 MRE | Chinese | Increased risk and poor survival | 161 |
SET8 3′ UTR | rs16917496 C/T | miR-502 MRE | Asian | Earlier age of onset | 162 |
TGFBR1 3′ UTR | rs334348 A/G | miR-628-5p MRE | Italian | Increased risk | 154 |
TGFB1 Exonic | rs1982073 C/T | miR-187 MRE | Italian | Increased risk | 154 |
XRCC1 Exonic | rs1799782 T/C | miR-138 MRE | Italian | Decreased risk | 154 |
AGO4 | rs7354931 C/A | miRNA RISC-loading, | African Americans | Decreased overall risk | 33 |
miRNA–RISC activity | European Americans | No risk association | |||
rs16822342 A/G | African Americans | Decreased risk of ER+ BC | 33 | ||
European Americans | No risk association | ||||
rs3820276 G/C | African Americans | Increased risk of ER+ BC | 33 | ||
European Americans | No risk association | ||||
DGCR8 | rs417309 G/A | Pre-miRNA | Chinese | Increased risk | 42 |
rs9606241 A/G | processing | African Americans | No risk association | 33 | |
European Americans | Increased risk of ER+ BC | ||||
PACT | rs2059691 G/A | miRNA–RISC activity | African Americans | No risk association | 33 |
European Americans | Increased overall risk | ||||
XPO5 | rs11077 A/C | Pre-miRNA | African Americans | Decreased risk of ER+ BC | 33 |
nuclear export | European Americans | No risk association |
Abbreviations: BC, breast cancer; ER, estrogen receptor; HER2, human EGF-like receptor 2; miRNA, microRNA; MRE, microRNA recognition element (ie, binding site); RISC, RNA-induced silencing complex; UTR, untranslated region.